RAMP Stock Analysis: Liveramp Holdings | NYSE
Software - Infrastructure | NYSE, USA | Market Cap: 2.283m USD | 12M Return: 36.9% | US53815P1084 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 44.3M
EPS Trend: 95.4%
Qual. Beats: 0
Rev. Trend: 99.4%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
LiveRamp Holdings, Inc. (NYSE: RAMP) is a technology company that operates a data collaboration platform enabling organizations to unify customer and prospect data into a single customer view while emphasizing consumer privacy. Its platform supports people-based marketing solutions across data collaboration, activation, measurement and analytics, identity, and data marketplace functionality. The company sells to enterprise marketers, agencies, marketing technology providers, publishers, and data providers across a wide range of verticals including financial services, retail, automotive, telecommunications, healthcare, and media.
Headquartered in San Francisco, California, LiveRamp was incorporated in 2018 after rebranding from Acxiom Holdings, Inc. (the original IPO dates to 1987), and serves customers primarily in the United States, Europe, and the Asia-Pacific region. The company operates in the broader marketing technology (martech) and ad-tech ecosystem, where data connectivity and identity resolution have become central infrastructure as the industry moves away from cookies and third-party tracking toward privacy-first, people-based targeting.
- Cookie deprecation drives demand for identity resolution platform
- Subscription revenue growth accelerates amid enterprise data collaboration adoption
- Privacy regulations boost demand for cookieless marketing solutions
| Net Income: 155.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA 3.65 > 1.0 |
| NWC/Revenue: 47.64% < 20% (prev 53.64%; Δ -6.00% < -1%) |
| CFO/TA 0.16 > 3% & CFO 201.8m > Net Income 155.7m |
| Net Debt (-337.9m) to EBITDA (117.5m): -2.87 < 3 |
| Current Ratio: 2.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (61.8m) vs 12m ago -7.32% < -2% |
| Gross Margin: 70.82% > 18% (prev 70.90%; Δ -0.08% > 0.5%) |
| Asset Turnover: 66.28% > 50% (prev 62.04%; Δ 4.24% > 0%) |
| Interest Coverage Ratio: 10.4k > 6 (EBIT TTM 104.2m / Interest Expense TTM 10.0k) |
| A: 0.31 (Total Current Assets 635.7m - Total Current Liabilities 239.2m) / Total Assets 1.28b |
| B: 1.15 (Retained Earnings 1.48b / Total Assets 1.28b) |
| C: 0.08 (EBIT TTM 104.2m / Avg Total Assets 1.26b) |
| D: 3.24 (Book Value of Equity 977.4m / Total Liabilities 301.4m) |
| Altman-Z'' = 9.76 = AAA |
| DSRI: 0.91 (Receivables 222.9m/225.9m, Revenue 832.1m/764.4m) |
| GMI: 1.00 (GM 70.90% / 70.82%) |
| AQI: 1.03 (AQ_t 0.48 / AQ_t-1 0.47) |
| SGI: 1.09 (Revenue 832.1m / 764.4m) |
| TATA: -0.04 (NI 155.7m - CFO 201.8m) / TA 1.28b) |
| Beneish M = -3.02 (Cap -4..+1) = AA |
As of October 16, 2026, the stock is trading at USD 37.55 with a total of 1,362,489 shares traded. Over the past week, the price has changed by +0.00%, over one month by -0.11%, over three months by -0.87% and over the past year by +36.91%.
Current recommended Stop Loss: 37.30 (which is 0.7% or 1.5 ATR below the current price).
Liveramp Holdings has received a consensus analysts rating of 3.67. Therefore, it is recommended to hold RAMP.
- StrongBuy: 2
- Buy: 0
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 38.7 | 3.1% |
P/E Trailing = 15.5207
P/E Forward = 200.0
P/S = 2.7442
P/B = 2.3288
P/EG = 0.5918
Revenue TTM = 832.1m USD
EBIT TTM = 104.2m USD
EBITDA TTM = 117.5m USD
Long Term Debt = 22.3m USD (estimated: total debt 33.1m - short term 10.8m)
Short Term Debt = 10.8m USD (from shortTermDebt, last quarter)
Debt = 33.1m USD (from shortLongTermDebtTotal, last quarter) (leases 33.1m already included)
Net Debt = -337.9m USD (calculated: Debt 33.1m - CCE 371.0m)
Enterprise Value = 1.95b USD (2.28b + Debt 33.1m - CCE 371.0m)
Interest Coverage Ratio = 10.4k (Ebit TTM 104.2m / Interest Expense TTM 10.0k)
EV/FCF = 9.71x (Enterprise Value 1.95b / FCF TTM 200.4m)
FCF Yield = 10.30% (FCF TTM 200.4m / Enterprise Value 1.95b)
FCF Margin = 24.08% (FCF TTM 200.4m / Revenue TTM 832.1m)
Net Margin = 18.71% (Net Income TTM 155.7m / Revenue TTM 832.1m)
Gross Margin = 70.82% ((Revenue TTM 832.1m - Cost of Revenue TTM 242.8m) / Revenue TTM)
Gross Margin QoQ = 70.54% (prev 70.62%)
Tobins Q-Ratio = 1.52 (Enterprise Value 1.95b / Total Assets 1.28b)
Interest Expense / Debt = 0.03% (Interest Expense 10.0k / Debt 33.1m)
Taxrate = 24.68% (5.74m / 23.3m)
NOPAT = 78.5m (EBIT 104.2m * (1 - 24.68%))
Current Ratio = 2.66 (Total Current Assets 635.7m / Total Current Liabilities 239.2m)
Debt / Equity = 0.03 (Debt 33.1m / totalStockholderEquity, last quarter 977.4m)
Debt / EBITDA = -2.87 (Net Debt -337.9m / EBITDA 117.5m)
Debt / FCF = -1.69 (Net Debt -337.9m / FCF TTM 200.4m)
Total Stockholder Equity = 963.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 12.40% (Net Income 155.7m / Total Assets 1.28b)
RoE = 16.16% (Net Income TTM 155.7m / Total Stockholder Equity 963.9m)
RoCE = 10.57% (EBIT 104.2m / Capital Employed (Equity 963.9m + L.T.Debt 22.3m))
RoIC = 7.78% (NOPAT 78.5m / Invested Capital 1.01b)
WACC = 8.79% (E(2.28b)/V(2.32b) * Re(8.92%) + D(33.1m)/V(2.32b) * Rd(0.03%) * (1-Tc(0.25)))
Discount Rate = 8.92% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -88.88 | Cagr: -4.09%
[DCF] Terminal Value 76.55% ; FCFF base≈179.4m ; Y1≈205.7m ; Y5≈302.7m
[DCF] Fair Price = 75.07 (EV 4.23b - Net Debt -337.9m = Equity 4.56b / Shares 60.8m; r=8.79% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 95.44 | EPS CAGR: 15.86% | SUE: -0.34 | # QB: 0
Revenue Correlation: 99.44 | Revenue CAGR: 11.30% | SUE: 0.67 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.76 | Chg30d=+10.14% | Revisions=+0% | Analysts=1
EPS next Quarter (2026-12-31): EPS=0.86 | Chg30d=+0.58% | Revisions=-25% | Analysts=1
EPS current Year (2027-03-31): EPS=2.88 | Chg30d=-2.54% | Revisions=-25% | GrowthEPS=+26.7% | GrowthRev=+9.0%
EPS next Year (2028-03-31): EPS=3.45 | Chg30d=+7.59% | Revisions=-25% | GrowthEPS=+20.0% | GrowthRev=+9.9%
[Analyst] Revisions Ratio: -50% (up=0, down=3)